Literature DB >> 9610732

Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects.

P A Garner-Hamrick1, C Fisher.   

Abstract

Cell cycle progression in mammalian cells is regulated by a family of cyclin-dependent kinases (cdks) that are activated by a family of 3 cdc25 phosphatases: cdc25A, cdc25B and cdc25C. We examined the expression of mRNA and protein of all 3 cdc25s during the HeLa cell cycle, and found that cdc25B protein has a unique and limited pattern of expression relative to other cdc25 homologs. Antisense oligonucleotides reduced cdc25B mRNA levels and dysregulated protein expression, while inhibiting S-phase progression in synchronized HeLa cells. Scrambled control oligonucleotides had no effect. Antisense oligonucleotides transfected in early G2-phase had no effect on cell cycle progression. A direct correlation between down-regulation of cdc25B and inhibition of thymidine incorporation was found using several oligonucleotides. Our results suggest a role for cdc25B in S-phase and demonstrate that inhibition of cdc25B has persistent antiproliferative effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610732     DOI: 10.1002/(sici)1097-0215(19980529)76:5<720::aid-ijc18>3.0.co;2-7

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

2.  Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.

Authors:  Lynn J Poole; Yanxing Yu; Peter S Kim; Qi-Zhi Zheng; Jonathan Pevsner; Gary S Hayward
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Genetic interaction between two insulin-dependent diabetes susceptibility loci, Idd2 and Idd13, in determining immunoregulatory DN T cell proportion.

Authors:  Roxanne Collin; Kathy Doyon; Victor Mullins-Dansereau; Martin Karam; Geneviève Chabot-Roy; Erin E Hillhouse; Alexandre Orthwein; Sylvie Lesage
Journal:  Immunogenetics       Date:  2018-04-25       Impact factor: 2.846

Review 4.  Proteasome-dependent degradation of human CDC25B phosphatase.

Authors:  C Cans; B Ducommun; V Baldin
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

5.  Identification of a C-terminal cdc25 sequence required for promotion of germinal vesicle breakdown.

Authors:  E A Powers; D P Thompson; P A Garner-Hamrick; W He; A W Yem; C A Bannow; D J Staples; G A Waszak; C W Smith; M R Deibel; C Fisher
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

6.  Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage.

Authors:  Béatrix Bugler; Estelle Schmitt; Bernadette Aressy; Bernard Ducommun
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

7.  Tumor suppressors and cell-cycle proteins in lung cancer.

Authors:  Alfonso Baldi; Antonio De Luca; Vincenzo Esposito; Mara Campioni; Enrico P Spugnini; Gennaro Citro
Journal:  Patholog Res Int       Date:  2011-10-05

Review 8.  Phosphatases in Mitosis: Roles and Regulation.

Authors:  Margarida Moura; Carlos Conde
Journal:  Biomolecules       Date:  2019-02-07

9.  B-Myb is critical for proper DNA duplication during an unperturbed S phase in mouse embryonic stem cells.

Authors:  Maëlle Lorvellec; Stéphanie Dumon; Apolinar Maya-Mendoza; Dean Jackson; Jon Frampton; Paloma García
Journal:  Stem Cells       Date:  2010-10       Impact factor: 6.277

Review 10.  Targeting the cell cycle for cancer therapy.

Authors:  A Carnero
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.